These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 28993607

  • 41. Liver transplantation for hepatocellular carcinoma: single nodule with Child-Pugh class A sized less than 3 cm.
    Moon DB, Lee SG, Hwang S.
    Dig Dis; 2007; 25(4):320-8. PubMed ID: 17960067
    [Abstract] [Full Text] [Related]

  • 42. Liver transplantation versus liver resection in the treatment of hepatocellular carcinoma: a meta-analysis of observational studies.
    Zheng Z, Liang W, Milgrom DP, Zheng Z, Schroder PM, Kong NS, Yang C, Guo Z, He X.
    Transplantation; 2014 Jan 27; 97(2):227-34. PubMed ID: 24142034
    [Abstract] [Full Text] [Related]

  • 43. [Factors for predicting outcomes of liver transplantation and liver resection for hepatocellular carcinoma meeting Milan criteria].
    Huang J, Zhou J.
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar 27; 34(3):406-9. PubMed ID: 24670459
    [Abstract] [Full Text] [Related]

  • 44. Population-Based Analysis of Hepatocellular Carcinoma in Children: Identifying Optimal Surgical Treatment.
    Ziogas IA, Ye F, Zhao Z, Matsuoka LK, Montenovo MI, Izzy M, Benedetti DJ, Lovvorn HN, Gillis LA, Alexopoulos SP.
    J Am Coll Surg; 2020 Jun 27; 230(6):1035-1044.e3. PubMed ID: 32272204
    [Abstract] [Full Text] [Related]

  • 45. Cirrhosis and microvascular invasion predict outcomes in hepatocellular carcinoma.
    Barreto SG, Brooke-Smith M, Dolan P, Wilson TG, Padbury RT, Chen JW.
    ANZ J Surg; 2013 May 27; 83(5):331-5. PubMed ID: 22943449
    [Abstract] [Full Text] [Related]

  • 46. Liver Resection for Early Hepatocellular Carcinoma: Preoperative Predictors of Non Transplantable Recurrence and Implications for Treatment Allocation.
    Gelli M, Sebagh M, Porcher R, Romanelli E, Vibert E, Sa Cunha A, Castaing D, Rosmorduc O, Samuel D, Adam R, Cherqui D.
    Ann Surg; 2020 Nov 27; 272(5):820-826. PubMed ID: 32833755
    [Abstract] [Full Text] [Related]

  • 47. Infection with hepatitis C virus is an adverse prognostic factor after liver resection for early-stage hepatocellular carcinoma: implications for the management of hepatocellular carcinoma eligible for liver transplantation.
    Chirica M, Tranchart H, Tan V, Faron M, Balladur P, Paye F.
    Ann Surg Oncol; 2013 Jul 27; 20(7):2405-12. PubMed ID: 23338483
    [Abstract] [Full Text] [Related]

  • 48. Hepatocellular carcinoma in liver transplant era: a clinicopathologic analysis.
    Nart D, Arikan C, Akyildiz M, Yuce G, Demirpolat G, Zeytunlu M, Karasu Z, Aydogdu S, Killi R, Yuzer Y, Tokat Y, Kilic M.
    Transplant Proc; 2003 Dec 27; 35(8):2986-90. PubMed ID: 14697957
    [Abstract] [Full Text] [Related]

  • 49. Defining Optimal Surgical Treatment for Recurrent Hepatocellular Carcinoma: A Propensity Score Matched Analysis.
    Ma KW, Chok KSH, She WH, Chan ACY, Cheung TT, Dai WC, Fung JYY, Lo CM.
    Liver Transpl; 2018 Aug 27; 24(8):1062-1069. PubMed ID: 29451360
    [Abstract] [Full Text] [Related]

  • 50. Liver transplantation vs liver resection in patients with HBV-related hepatocellular carcinoma beyond Milan criterion: A meta-analysis.
    Li W, Li L, Han J, Wu H.
    Clin Transplant; 2018 Mar 27; 32(3):e13193. PubMed ID: 29315813
    [Abstract] [Full Text] [Related]

  • 51. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis.
    Otto G, Heuschen U, Hofmann WJ, Krumm G, Hinz U, Herfarth C.
    Ann Surg; 1998 Mar 27; 227(3):424-32. PubMed ID: 9527066
    [Abstract] [Full Text] [Related]

  • 52. Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis.
    Lee MW, Raman SS, Asvadi NH, Siripongsakun S, Hicks RM, Chen J, Worakitsitisatorn A, McWilliams J, Tong MJ, Finn RS, Agopian VG, Busuttil RW, Lu DSK.
    Hepatology; 2017 Jun 27; 65(6):1979-1990. PubMed ID: 28170115
    [Abstract] [Full Text] [Related]

  • 53. Hepatocellular carcinoma in Child's A cirrhosis: a retrospective analysis of matched pairs following liver transplantation vs. liver resection according to the intention-to-treat principle.
    Foltys D, Zimmermann T, Kaths M, Strempel M, Heise M, Hoppe-Lotichius M, Weiler N, Scheuermann U, Ruckes C, Hansen T, Pitton M, Otto G.
    Clin Transplant; 2014 Jan 27; 28(1):37-46. PubMed ID: 24171713
    [Abstract] [Full Text] [Related]

  • 54. Recurrence rate and transplantability after liver resection in patients with hepatocellular carcinoma who initially met transplantation criteria.
    Tanaka H, Kubo S, Tsukamoto T, Shuto T, Takemura S, Yamamoto T, Okuda T, Kanazawa A, Hirohashi K.
    Transplant Proc; 2005 Mar 27; 37(2):1254-6. PubMed ID: 15848687
    [Abstract] [Full Text] [Related]

  • 55. Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience.
    Del Gaudio M, Ercolani G, Ravaioli M, Cescon M, Lauro A, Vivarelli M, Zanello M, Cucchetti A, Vetrone G, Tuci F, Ramacciato G, Grazi GL, Pinna AD.
    Am J Transplant; 2008 Jun 27; 8(6):1177-85. PubMed ID: 18444925
    [Abstract] [Full Text] [Related]

  • 56. Salvage liver transplantation for patients with recurrent hepatocellular carcinoma after curative resection.
    Wu L, Hu A, Tam N, Zhang J, Lin M, Guo Z, He X.
    PLoS One; 2012 Jun 27; 7(7):e41820. PubMed ID: 22848619
    [Abstract] [Full Text] [Related]

  • 57. Complete pathologic response to pretransplant locoregional therapy for hepatocellular carcinoma defines cancer cure after liver transplantation: analysis of 501 consecutively treated patients.
    Agopian VG, Morshedi MM, McWilliams J, Harlander-Locke MP, Markovic D, Zarrinpar A, Kaldas FM, Farmer DG, Yersiz H, Hiatt JR, Busuttil RW.
    Ann Surg; 2015 Sep 27; 262(3):536-45; discussion 543-5. PubMed ID: 26258323
    [Abstract] [Full Text] [Related]

  • 58. Locoregional Therapy With Curative Intent Versus Primary Liver Transplant for Hepatocellular Carcinoma: Systematic Review and Meta-Analysis.
    Murali AR, Patil S, Phillips KT, Voigt MD.
    Transplantation; 2017 Aug 27; 101(8):e249-e257. PubMed ID: 28282359
    [Abstract] [Full Text] [Related]

  • 59. Surgical results for recurrent hepatocellular carcinoma after curative hepatectomy: Repeat hepatectomy versus salvage living donor liver transplantation.
    Yamashita Y, Yoshida Y, Kurihara T, Itoh S, Harimoto N, Ikegami T, Yoshizumi T, Uchiyama H, Shirabe K, Maehara Y.
    Liver Transpl; 2015 Jul 27; 21(7):961-8. PubMed ID: 25772591
    [Abstract] [Full Text] [Related]

  • 60. The timing of liver transplantation after primary hepatectomy for hepatocellular carcinoma: a special reference to recurrence pattern and Milan criteria.
    Ikegami T, Shimada M, Imura S, Yoshizumi T, Arakawa Y, Tokunaga T, Morine Y, Kanemura H.
    Transplantation; 2008 Sep 15; 86(5):641-6. PubMed ID: 18791443
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.